Tedford CE, Hoffmann M, Seyedi N, et al: High antagonist potency of GT-2227 and GT-2331, new histamine H3 receptor antagonists, in two functional models. In: Eur. J. Pharmacol. 351. Jahrgang, Nr.3, Juni 1998, S.307–311, doi:10.1016/S0014-2999(98)00396-3, PMID 9721022.
Krueger KM, Witte DG, Ireland-Denny L, et al: G protein-dependent pharmacology of histamine H3 receptor ligands: evidence for heterogeneous active state receptor conformations. In: J. Pharmacol. Exp. Ther. 314. Jahrgang, Nr.1, Juli 2005, S.271–281, doi:10.1124/jpet.104.078865, PMID 15821027.
Liu H, Kerdesky FA, Black LA, et al: An efficient multigram synthesis of the potent histamine H3 antagonist GT-2331 and the reassessment of the absolute configuration. In: J. Org. Chem. 69. Jahrgang, Nr.1, Januar 2004, S.192–194, doi:10.1021/jo035264t, PMID 14703397.
Tedford CE, Hoffmann M, Seyedi N, et al: High antagonist potency of GT-2227 and GT-2331, new histamine H3 receptor antagonists, in two functional models. In: Eur. J. Pharmacol. 351. Jahrgang, Nr.3, Juni 1998, S.307–311, doi:10.1016/S0014-2999(98)00396-3, PMID 9721022.
Krueger KM, Witte DG, Ireland-Denny L, et al: G protein-dependent pharmacology of histamine H3 receptor ligands: evidence for heterogeneous active state receptor conformations. In: J. Pharmacol. Exp. Ther. 314. Jahrgang, Nr.1, Juli 2005, S.271–281, doi:10.1124/jpet.104.078865, PMID 15821027.
Liu H, Kerdesky FA, Black LA, et al: An efficient multigram synthesis of the potent histamine H3 antagonist GT-2331 and the reassessment of the absolute configuration. In: J. Org. Chem. 69. Jahrgang, Nr.1, Januar 2004, S.192–194, doi:10.1021/jo035264t, PMID 14703397.
